Regulatory & Legal

Sarepta will unveil crucial long-term data for its Duchenne gene therapy and exon-skipping drugs at MDA 2026, a pivotal moment for patients and the company.

A key partnership ensures the supply of a breakthrough therapy for FOP, a devastating condition where muscle turns to bone, highlighting a new era in drug production.

The Swedish freight-tech firm secures new funding for its SPAC merger, fueling a global push for its electric and autonomous trucking ecosystem.

Beyond software, an Upstate NY incubator is tackling global challenges in health, climate, and ag-tech, turning physical ideas into world-changing products.

The 401(k) provider hires sales and regulatory leaders to capitalize on surging demand from small businesses and navigate complex new retirement laws.

A new skincare brand is skipping mass marketing, embedding its products with veterans, skiers, and melanoma researchers to redefine sun protection.

Flexport launches a suite of AI tools to audit customs, optimize shipping, and process tariff refunds, aiming to create a fully autonomous supply chain.

A new order extends a decade-long partnership, highlighting CPI Aero's key role in the supply chain of Embraer's best-selling Phenom 300 business jet.

Engineered by NIST to last centuries, America's official time capsule will be sealed in 2026. What story of us will it tell future generations?

The partnership aims to modernize VHC Health’s IT infrastructure, enhance cybersecurity, and improve the clinician experience through cloud migration and AI.

Exceptional new drilling results bolster the Spanish Mountain Gold project, pointing to a larger resource and advancing its 'greenest mine' ambitions.

Infrastructure software giant posts 11% revenue growth, outlines a bullish 2026 forecast, and doubles down on AI with key acquisitions.

On the war's fourth anniversary, Kyivstar's board, including Mike Pompeo, visited Kyiv, reaffirming a $1B investment and honoring resilient employees.

Kairos Pharma aims to reshape lung cancer treatment by acquiring two AI-designed drugs, targeting a key resistance mechanism in a multi-billion dollar market.

As colorectal cancer rates rise in younger adults, advocates demand provinces lower the screening age. But will policymakers act on the growing evidence?

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

With record SUBLOCADE revenue and a new U.S. home, Indivior launches a $400M buyback, signaling a new era in its fight against the opioid crisis.

A new collaboration is betting on tiny natural particles to deliver a gene-editing cure for a devastating neurological disorder, bypassing a key medical hurdle.

Eos Energy reports record revenue and a fortified balance sheet, resolving 'going concern' doubts, but sets 2026 guidance below analyst expectations.

Zoomcar's latest financing move involves complex warrants, raising questions about shareholder dilution and its strategy in India's car-sharing race.